EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Enhanced Recombinant Adeno‐Associated Virus (rAAV) Biomanufacturing: Design of Experiment (DOE) Enabled Transfection Optimization for Maximum Full Capsid Yield and Robust Scale‐Up

Alexandra Bogdanovic iD, Nicholas Donohue iD, Brian Glennon iD, Susan Mc Donnell, Jessica Whelan iD

Biotechnology Journal · 2026-06 · 21 (6)

DOI: 10.1002/biot.70249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 28.05.2026. Verfasst von Alexandra Bogdanovic und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Bioprocess Engineering, University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Dependovirus, Transfection, Genetic Vectors, Capsid. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Irish Research Council (Taighde Éireann), Enterprise Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno‐associated virus (rAAV) gene therapies are a promising class of therapeutics. While their production via triple transfection in a single cell line offers flexibility regarding modification of the transgene, it faces significant challenges, particularly regarding predominance of empty capsids, reproducibility of process performance (titre and product quality), and successful scale‐up. This study addresses these limitations by employing a two‐stage Design of Experiment (DOE) approach to optimize triple transfection for rAAV5 viral vector production. An initial screening design systematically evaluated a comprehensive set of factors for their impact on transfection efficiency, genome titre, capsid titre, and the ratio of full to empty capsids. Four highly influential factors identified during screening were further investigated in a second‐stage response surface design. Statistical analysis confirmed that DNA amount, complexation time, FectoVir‐AAV volume, and the ratio of pTransgene were the most critical determinants of performance. The optimal conditions were successfully scaled up from 6 well plates to a 50 L Wave reactor. Coupled with the implementation of an alternative harvest strategy, transfection efficiencies, capsid, and genome titre were maintained while there was an increase in % full capsids to 73% at scale demonstrating a viable, robust, and scalable manufacturing strategy for high‐quality rAAV5 vectors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusTransfectionGenetic VectorsCapsidHumansHEK293 Cells

Stichwörter der Autor:innen

adeno‐associated virusdesign of experimentprocess scale‐up

Autor:innen und Institutionen

  • School of Chemical and Bioprocess Engineering, University College Dublin, Dublin, Ireland.
  • APC Ltd, Cherrywood, Dublin, Ireland.
  • Synthesis and Solid-State Pharmaceutical Centre (SSPC), Limerick, Ireland.
  • Conway Institute of Biomolecular & Biomedical Research, University College Dublin, Dublin, Ireland.

ORCID-Profile: Alexandra Bogdanovic, Nicholas Donohue, Brian Glennon, Jessica Whelan

Förderung

  • Irish Research Council (Taighde Éireann)
  • Enterprise Ireland

Zitieren

APA

Bogdanovic, A., Donohue, N., Glennon, B., Donnell, S. M., & Whelan, J. (2026). Enhanced Recombinant Adeno‐Associated Virus (rAAV) Biomanufacturing: Design of Experiment (DOE) Enabled Transfection Optimization for Maximum Full Capsid Yield and Robust Scale‐Up. Biotechnology Journal, 21(6). https://doi.org/10.1002/biot.70249

Vancouver

Bogdanovic A, Donohue N, Glennon B, Donnell SM, Whelan J. Enhanced Recombinant Adeno‐Associated Virus (rAAV) Biomanufacturing: Design of Experiment (DOE) Enabled Transfection Optimization for Maximum Full Capsid Yield and Robust Scale‐Up. Biotechnology Journal. 2026;21(6). doi:10.1002/biot.70249

BibTeX
@article{Bogdanovic2026,
  author = {Bogdanovic, Alexandra and Donohue, Nicholas and Glennon, Brian and Donnell, Susan Mc and Whelan, Jessica},
  title = {Enhanced Recombinant Adeno‐Associated Virus (rAAV) Biomanufacturing: Design of Experiment (DOE) Enabled Transfection Optimization for Maximum Full Capsid Yield and Robust Scale‐Up},
  journal = {Biotechnology Journal},
  year = {2026},
  volume = {21},
  number = {6},
  doi = {10.1002/biot.70249}
}
Kostenlos starten →